Elevara Medicines Raises $70 Million Series A to Advance Phase 2 Rheumatoid Arthritis Trial and Expand Pipeline [Yahoo! Finance]
TEIJIN LTD ADR (TINLY)
NASDAQ:AMEX Investor Relations:
teijin.com/ir
Company Research
Source: Yahoo! Finance
Innovative lead program, ELV001, in-licensed by Elevara from Japan's Teijin Pharma with good tolerability and safety, plus early signs of efficacy in Phase 1b Disrupting the treatment paradigm for patients with incomplete response to Standard of Care (Methotrexate + Tumor Necrosis Factor inhibitors (TNFi)) London, UK – 22 October 2025 – Elevara Medicines (“Elevara”), a clinical-stage biotech developing therapies for rheumatoid arthritis (RA) and chronic inflammatory diseases, today announced the close of a $70 million Series A financing. The round was co-led by Forbion and Sofinnova Partners, with participation from founding investor, Monograph Capital. The Series A proceeds will fund Elevara's upcoming Phase 2 clinical trial of its lead candidate ELV001 and support exploratory programs in additional chronic inflammatory conditions and women's health. The START-SYNERGY Phase 2 trial will enroll approximately 180 patients with inadequate response to methotrexate and TNF inhibito
Show less
Read more
Impact Snapshot
Event Time:
TINLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TINLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TINLY alerts
High impacting TEIJIN LTD ADR news events
Weekly update
A roundup of the hottest topics
TINLY
News
- A Fresh Look at Teijin (TSE:3401) Valuation After Recent Share Price Pullback [Yahoo! Finance]Yahoo! Finance
- Is Teijin's Recent Share Price Drop an Opportunity After Advanced Materials News? [Yahoo! Finance]Yahoo! Finance
- Teijin pilots digital product passports to track recycled PC in EV supply chains [Yahoo! Finance]Yahoo! Finance
- What Does Teijin's Quiet 2025 Mean for Investors After DCF and Sales Analysis? [Yahoo! Finance]Yahoo! Finance